![](/img/cover-not-exists.png)
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells
Etchin, J, Berezovskaya, A, Conway, A S, Galinsky, I A, Stone, R M, Baloglu, E, Senapedis, W, Landesman, Ysef, Kauffman, M, Shacham, Sron, Wang, J C Y, Look, A TLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2016.145
Date:
May, 2016
File:
PDF, 1.80 MB
english, 2016